| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Research Laboratories, Chemie, Grünenthal GmbH, Stolberg/Rheinland, Germany
The survival time of rats with 7,12-dimethylbenzanthracene-induced tumors is significantly increased by treatment with the combination of the cyclic imide 1-(morpholinomethyl)-4-phthalimido-piperidindione-2,6 and drostanolone propionate (2
-methyl dihydrotestosterone propionate). In long-term treatment the antitumor activity, determined by the number of the tumor centers, is likewise significantly increased compared with the effect of the combination components alone.
Received 4/ 1/69. Accepted 6/24/69.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |